LIGAND PHARMACEUTICALS INCORPORATED Taxes Payable, Current
LIGAND PHARMACEUTICALS INCORPORATED (LGND) had Taxes Payable, Current of $3.22 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current › Taxes Payable, Current
us-gaap:TaxesPayableCurrent · last filed 2026-08-07
- 2026-06-30: Taxes Payable, Current $3.22M.
- 2026-03-31: Taxes Payable, Current $1.89M.
- 2025-12-31: Taxes Payable, Current $1.24M.
- 2025-09-30: Taxes Payable, Current $1.28M.
| Period end | Taxes Payable, Current |
|---|---|
| 2026-06-30 | $3.22M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $1.89M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $1.24M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $1.28M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $305.00K 10-Q · filed 2025-08-08 |
| 2025-03-31 | $1.80M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $1.20M 10-K · filed 2026-02-27 |
| 2024-09-30 | $2.11M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $2.09M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $1.14M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $0.00 10-Q · filed 2024-11-08 |
| 2023-09-30 | $1.20M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $11.39M 10-Q · filed 2023-08-09 |
| 2022-12-31 | $0.00 10-Q · filed 2023-11-09 |
| 2022-09-30 | $9.70M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $3.78M 10-Q · filed 2022-08-09 |
| 2021-12-31 | $0.00 10-Q · filed 2022-11-08 |
| 2020-09-30 | $674.00K 10-Q · filed 2020-11-06 |
| 2019-12-31 | $0.00 10-Q · filed 2020-11-06 |